Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Late effects of pelvic rhabdomyosarcoma in female survivors analyzed
December 15th, 2005
Late effects of pelvic rhabdomyosarcoma in female survivors were analyzed. Researchers in the United States conducted a study "to document the spectrum and severity of late effects in female survivors of pelvic rhabdomyosarcoma. We reviewed the demographic, diagnostic, treatment, and outcome data of the 26 females treated for pelvic rhabdomyosarcoma at our institution between March 1962 and December 1996 who survived free of disease for 5 or more years. Adverse effects that occurred 5 or more years after diagnosis were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0." "The most common...
Source: Women's Health Weekly (2005-12-15)
|
